TPT1 and cancer: Furthermore, the knockdown of TCTP has been demonstrated to synergistically suppress the mTORC1 pathway in combination with rapamycin [45] This finding indicated that TCTP may represent a promising target for overcoming rapamycin resistance in cancer therapy.